Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene

Domenico Girelli, Claudia Bozzini, Antonella Roetto, Federica Alberti, Filomena Daraio, Romano Colombari, Oliviero Olivieri, Roberto Corrocher, Clara Camaschella

Research output: Contribution to journalArticlepeer-review

Abstract

Background & Aims: Although most patients with hereditary hemochromatosis are homozygous for a single mutation of the HFE gene on chromosome 6p, accumulating evidence indicates that the disease is genetically heterogeneous. Type 3 hemochromatosis, recently described in 4 families, is linked to mutations of the gene encoding transferrin receptor 2 on chromosome 7q22. Here we report data from a family carrying a new mutation of the transferrin receptor 2 gene. Methods: Detailed clinical and histopathologic documentation was available for most family members. The entire coding sequence and exon/intron boundaries of the transferrin receptor 2 gene were analyzed by direct sequencing. Results: A 12-nucleotide deletion in exon 16, causing the loss of 4 amino acids (AVAQ 594-597 del), was detected at the homozygous state in the 3 patients with histologically proven iron overload. The deletion segregated with the disease within the family and was not found in 100 healthy controls. Some clinical and pathologic characteristics, such as low penetrance in the premenopausal woman, and early iron deposition in periportal hepatocytes resembled those of classic, HFE-related hemochromatosis. Conclusions: Our data support the role of the transferrin receptor 2 gene in hemochromatosis type 3 as well as its critical involvement in the maintenance of iron homeostasis in humans.

Original languageEnglish
Pages (from-to)1295-1302
Number of pages8
JournalGastroenterology
Volume122
Issue number5
Publication statusPublished - 2002

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene'. Together they form a unique fingerprint.

Cite this